Paul Baas - Publications, H-index & Citations

Paul Baas

Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital

83H指数

546论文数

4.5W被引数

收录论文 151

发表时间

The role of microRNAs and competing endogenous RNA regulatory networks in mesothelioma response to immunotherapy microRNAs和竞争性内源RNA调控网络在间皮瘤对免疫治疗反应中的作用

Lung Cancer

IF4.4

2026-05-22

PREAI

Farhad Kosari; Paul Baas; Maria Disselhorst; Kim Lauer; Tobias Peikert; Stephen Murphy; Janet Schaefer Klein; Aaron S. Mansfield

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC 不可切除的III期NSCLC放化疗后durvalumab的真实世界5年结局

ESMO Open

IF8.3

2026-02-04

OAAI

N. Girard; J. Bar; P. Baas; C. Chouaid; D.C. Christoph; J.K. Field; R. Fietkau; M.C. Garassino; P. Garrido Lopez; V. Gregorc; V.D. Haakensen; T.J.N. Hiltermann; S. Kao; F. McDonald; F. Mornex; M. Moskovitz; S. Peters; S. Siva; B. Solomon; Y. Qiao

Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung)可切除非小细胞肺癌患者术前纳武利尤单抗联合或不联合雷迪利单抗的长期结局（NEOpredict-Lung）

European Journal of Cancer

IF7.1

2025-12-05

PREAI

Kristof Cuppens; Marcel Wiesweg; Paul Baas; Brigitte Maes; Bert Du Pont; Till Ploenes; Dirk Theegarten; Michel Vanbockrijck; Clemens Aigner; Koen Hartemink; Fabian Doerr; Servet Bölükbas; Karin Pat; Martin Schuler

Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study 帕博利珠单抗联合仑伐替尼作为恶性胸膜间皮瘤患者的二线治疗方案（PEMMELA研究）：一项单臂、II期研究的队列2

The Lancet Oncology

IF0

2025-11-24

PREAI

Li-Anne H Douma; Vincent van der Noort; Ferry Lalezari; Jeltje F de Vries; Kim Monkhorst; Illaa Smesseim; Paul Baas; Bodien Schilder; Marrit Vermeulen; Jacobus A Burgers; Cornedine J de Gooijer

Discovery of actionable drug targets to enhance T-cell infiltration and immune checkpoint blockade efficacy in pleural mesothelioma 发现可操作的药物靶点以增强胸膜间皮瘤中T细胞浸润和免疫检查点阻断疗效

Lung Cancer

IF4.4

2025-09-28

PREAI

Jasper H.L.T. van Genugten; Daniel Faulkner; Jens C. Hahne; Charlotte Poile; Lodewyk Wessels; Dean A. Fennell; Paul Baas

Pleural mesothelioma 胸膜间皮瘤

Nature Reviews Disease Primers

IF60.6

2025-08-07

PREAI

Dean A. Fennell; Yoshitaka Sekido; Paul Baas; Aliya N. Husain; Alessandra Curioni-Fontecedro; Eric Lim; Isabelle Opitz; Charles B. Simone; Fraser Brims; Martin Chi-sang Wong

Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer 帕博利珠单抗联合放疗在免疫冷型非小细胞肺癌中诱导系统性抗肿瘤免疫应答

Nature Cancer

IF28.5

2025-07-22

OAAI

Justin Huang; Willemijn S. M. E. Theelen; Zineb Belcaid; Mimi Najjar; Daphne van der Geest; Dipika Singh; Christopher Cherry; Archana Balan; James R. White; Jaime Wehr; Rachel Karchin; Noushin Niknafs; Michel M. van den Heuvel; Victor E. Velculescu; Kellie N. Smith; Paul Baas; Valsamo Anagnostou

Advancing real-world research in thoracic malignancies: learnings from the international I-O Optimise initiative

FUTURE ONCOLOGY

IF2.6

2025-02-25

OAAI

Johnsen, Soren Paaske; Baas, Paul; Sorensen, Jens Benn; Chouaid, Christos; Griesinger, Frank; Daumont, Melinda J.; Rault, Caroline; Emanuel, Gabrielle; Penrod, John R.; Jacobs, Hazel; Muwaffak, Maha; Schoemaker, Minouk J.; Munro, Robin E. J.; Baskaran, Darshan; Durand-Zaleski, Isabelle; O'Donnell, John C.

A randomised phase II study of extended pleurectomy/ decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-06-06

OAAI

Raskin, Jo; Surmont, Veerle; Maat, Alexander P. W. M.; Yahia, Maha; Burgers, Sjaak A.; Pretzenbacher, Yassin; De Ryck, Frederic; Cornelissen, Robin; Klomp, Houke M.; Oliveira, Ana; Aerts, Joachim; Baas, Paul; Marreaud, Sandrine; Van Meerbeeck, Jan P.; Van Schil, Paul E. Y.

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial nivolumab联合或不联合relatlimab新辅助治疗可切除的非小细胞肺癌: 一项随机2期试验

NATURE MEDICINE

IF50

2024-04-30

OAAI

Schuler, Martin; Cuppens, Kristof; Ploenes, Till; Wiesweg, Marcel; Du Pont, Bert; Hegedus, Balazs; Koester, Johannes; Mairinger, Fabian; Darwiche, Kaid; Paschen, Annette; Maes, Brigitte; Vanbockrijck, Michel; Laehnemann, David; Zhao, Fang; Hautzel, Hubertus; Theegarten, Dirk; Hartemink, Koen; Reis, Henning; Baas, Paul; Schramm, Alexander; Aigner, Clemens

Combination pembrolizumab and radiotherapy induces anti-tumor immune responses in immunologically-cold non-small cell lung cancer

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Huang, Justin; Theelen, Willemijn S.; Belcaid, Zineb; Najjar, Mimi; Cherry, Christopher; Balan, Archana; White, James R.; Niknafs, Noushin; Wehr, Jaime; van den Heuvel, M. M.; Karchin, Rachel; Baas, Paul; Velculescu, Victor E.; Anagnostou, Valsamo

Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath 电子鼻分析呼出气前瞻性检测COPD患者在常规护理中的早期肺癌

CHEST

IF8.6

2023-11-01

OAAI

de Vries, Rianne; Farzan, Niloufar; Fabius, Timon; De Jongh, Frans H. C.; Jak, Patrick M. C.; Haarman, Eric G.; Snoey, Erik; Veen, Johannes C. C. M. In'T; Dagelet, Yennece W. F.; Maitland-Van Der Zee, Anke-Hilse; Lucas, Annelies; Van Den Heuvel, Michel M.; Wolf-Lansdorf, Marguerite; Muller, Mirte; Baas, Paul; Sterk, Peter J.

TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)

ANNALS OF ONCOLOGY

IF65.4

2023-11-01

PREAI

Kitazono, S.; Paz-Ares, L.; Ahn, M-J.; Lisberg, A. E.; Cho, B. C.; Blumenschein, G.; Shum, E.; Pons-Tostivint, E.; Goto, Y.; Yoh, K.; Heist, R.; Baas, P.; Planchard, D.; Perol, M.; Felip, E.; Su, W-C.; Zebger-Gong, H.; Lan, L.; Liu, C.; Sands, J.

LTROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

PREAI

Paz-Ares, L.; Ahn, M-J.; Lisberg, A. E.; Kitazono, S.; Cho, B. C.; Blumenschein, G.; Shum, E.; Pons-Tostivint, E.; Goto, Y.; Yoh, K.; Heist, R.; Baas, P.; Planchard, D.; Perol, M.; Felip, E.; Su, W-C.; Zebger-Gong, H.; Lan, L.; Liu, C.; Sands, J.

The path forward in early-stage lung cancer 早期肺癌的发展路径

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2023-01-01

OAAI

Cuppens, Kristof; Baas, Paul

Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project (vol 35, pg 1888, 2022)间皮瘤患者中磷酸化核糖体蛋白S6的表达-与临床病理特征和结果的相关性: 来自欧洲胸部肿瘤学平台 (ETOP) Mesoscape项目的结果 (第35卷，1888页，2022)

MODERN PATHOLOGY

IF5.5

2022-12-01

OAAI

Ruschoff, Jan Hendrik; Haberecker, Martina; Tsourti, Zoi; Nackaerts, Kristiaan; de Perrot, Marc; Brcic, Luka; Nadal, Ernest; Tsimpoukis, Sotirios; Gray, Steven G.; Ampollini, Luca; Aerts, Joachim G.; Felley-Bosco, Emanuela; Kirschner, Michaela B.; Monkhorst, Kim; Weynand, Birgit; Bavaghar-Zaeimi, Fatemeh; Samarzija, Miroslav; Llatjos, Roger; Finn, Stephen P.; Silini, Enrico; von der Thusen, Jan; Marti, Nesa; Vervita, Karerina; Kammler, Roswitha; Peters, Solange; Stahel, Rolf A.; Baas, Paul; Opitz, Isabelle

Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project 间皮瘤患者中磷酸化核糖体蛋白S6的表达-与临床病理特征和结果的相关性: 来自欧洲胸部肿瘤学平台 (ETOP) Mesoscape项目的结果

MODERN PATHOLOGY

IF5.5

2022-12-01

OAAI

Rueschoff, Jan Hendrik; Haberecker, Martina; Tsourti, Zoi; Nackaerts, Kristiaan; de Perrot, Marc; Brcic, Luka; Nadal, Ernest; Tsimpoukis, Sotirios; Gray, Steven G.; Ampollini, Luca; Aerts, Joachim G.; Felley-Bosco, Emanuela; Kirschner, Michaela B.; Monkhorst, Kim; Weynand, Birgit; Bavaghar-Zaeimi, Fatemeh; Samarzija, Miroslav; Llatjos, Roger; Finn, Stephen P.; Silini, Enrico; von der Thusen, Jan; Marti, Nesa; Vervita, Karerina; Kammler, Roswitha; Peters, Solange; Stahel, Rolf A.; Baas, Paul; Opitz, Isabelle

First-line nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with unresectable malignant pleural mesothelioma (uMPM): 4-year update from CheckMate 743

ANNALS OF ONCOLOGY

IF65.4

2022-09-01

OAAI

Zalcman, G.; Oulkhouir, Y.; Cornelissen, R.; Greillier, L.; Cid, J. R. Rodriguez; Mazieres, J.; Briggs, P.; Nowak, A. K.; Tsao, A.; Fujimoto, N.; Peters, S.; Mansfield, A. S.; Popat, S.; Nassar, A.; Bushong, J.; Hu, N.; Spires, T.; Balli, D.; Eccles, L.; Baas, P.

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743 一线nivolumab联合ipilimumab与化疗在不可切除的恶性胸膜间皮瘤患者中的比较: CheckMate 743的3年结果

ANNALS OF ONCOLOGY

IF65.4

2022-05-01

135

OAAI

Peters, S.; Scherpereel, A.; Cornelissen, R.; Oulkhouir, Y.; Greillier, L.; Kaplan, M. A.; Talbot, T.; Monnet, I; Hiret, S.; Baas, P.; Nowak, A. K.; Fujimoto, N.; Tsao, A. S.; Mansfield, A. S.; Popat, S.; Zhang, X.; Hu, N.; Balli, D.; Spires, T.; Zalcman, G.

Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib

PHARMACEUTICAL RESEARCH

IF4.3

2022-03-29

OAAI

Boosman, Rene J.; de Gooijer, Cornedine J.; Groenland, Stefanie L.; Burgers, Jacobus A.; Baas, Paul; van der Noort, Vincent; Beijnen, Jos H.; Huitema, Alwin D. R.; Steeghs, Neeltje

研究方向